5Walker PP, Reynolds MT, Ashbee HR, et aL Vaginal yeasts in the era of "over the counter" antifungals[ J]. Sex Transm Infect, 2000,76(6) :437-438. 被引量：1
6Richter SS , Galask RP,Messer SA , et al. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases[ J]. J Clin Microbiol ,2005 ,43 (5) :2155- 2162. 被引量：1
7Sobel JD, Wiesenfeid HC,Martens M, et al. Maintenance fluconazole therapy for recurrent vulvovaginal eandidiasis [ J ]. New Engl J Med,2004,351:876-883. 被引量：1
8Geiger AM, Foxman B, Sobel JD. Chronic vulvovaginal candidiasis: characteristics of women with Candida albicans, C glabrata and no candida [ J ]. Genitourin Med, 1995,71 ( 5 ) : 304-307. 被引量：1
9Shahid Z, Sobel JD. Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fiuconazole therapy [ J ]. Diagn Microbiol Infect Dis,2009,64:354-356. 被引量：1
10Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis [J ]. N Engl J Med,2005,353 ( 18 ) : 1899-1911. 被引量：1
